期刊文献+

小柴胡汤加减治疗慢性肾小球肾炎患者对炎症及蛋白尿改善的效果探讨 被引量:4

Study on Effect of Modified Xiaochaihu Decoction Treatment of Patients with Chronic Glomerulonephritis on the Improvement of Inflammation and Proteinuria
下载PDF
导出
摘要 目的探讨小柴胡汤加减治疗慢性肾小球肾炎患者对炎症及蛋白尿改善的效果。方法方便选取该院2016年9月—2017年9月接收的106例慢性肾小球肾炎患者作为研究对象,依据临床用药方案分成2组,对照组(51例)行常规治疗,实验组(55例)于此基础上行小柴胡汤加减治疗,比对2组治疗前后证候积分变化、炎症及蛋白尿改善情况。结果治疗后实验组证候积分(8.69±2.06)分比对照组显著更低,差异有统计学意义(t=11.175 7,P<0.05);治疗后实验组IL-4(42.25±20.45)pg/mL等炎症因子及Upro(1.30±0.74)g/24 h水平均显著优于对照组(t=3.525 2、2.712 6,P<0.05)。结论 CGN行小柴胡汤加减治疗可取得确切疗效,有效减轻患者肾炎及蛋白尿,可被临床推广、普及。 Objective To study the effect of modified xiaochaihu decoction treatment of patients with chronic glomerulonephritis on the improvement of inflammation and proteinuria. Methods 106 cases of patients with chronic glomerulonephritis admitted and treated in our hospital from September 2016 to September 2017 were convenient selected and divided into two groups according to the clinical mediation plans, the control group with 51 cases used the routine therapy,while the experimental group with 55 cases were treated with xiaochaihu decoction on the basis of the control group, and the syndrome score changes, and improvement of inflammation and proteinuria before and after treatment were compared.Results After treatment, the syndrome score in the experimental group was(8.69±2.06) marks, which was obviously lower than that in the control group,the difference was statistically significant(t=11.175 7,P〈0.05); after treatment, the IL-4 and Upro in the experimental group were respectively(42.25 ±20.45)pg/mL and(1.30 ±0.74)g/24 h, which were obviously better than those in the control group,(t=3.525 2, 2.712 6,P〈0.05). Conclusion The modified xiaochaihu decoction in treatment of CGN can obtain a definite curative effect, which can effectively relieve the nephritis and proteinuria, and it can be promoted in clinic.
作者 张晓艳 张雪琴 ZHA NG Xiao-yan;ZHA NG Xue-qin(Department of Nephrology,Affiliated Hospital of Shared University of Traditional Chinese Medicine,Taiyuan,Shared Province,030024 Chin)
出处 《中外医疗》 2018年第9期159-161,共3页 China & Foreign Medical Treatment
关键词 小柴胡汤加减 慢性肾小球肾炎 炎症 蛋白尿 Modified xiaoehaihu decoction Chronic glomerulonephritis Inflammation Proteinuria
  • 相关文献

参考文献10

二级参考文献80

  • 1徐晓月,张陆勇,江振洲.马兜铃酸Ⅰ肾毒性的实验研究[J].中国生化药物杂志,2006,27(6):336-339. 被引量:13
  • 2李静,杨洪涛,邢海涛.活血软坚法治疗慢性肾小球肾炎的临床观察[J].天津中医药,2007,24(3):203-204. 被引量:1
  • 3王海燕.肾脏病学[M]2版[M].北京:人民卫生出版社,1997.1481-1522.
  • 4中华人民共和国卫生部.中药新药临床研究指导原则[S].北京:中国医药科技出版社,1993:6-10
  • 5Teratani G,Awano S,Soh I. Oral health in patients on haemodialysis for diabetic nephropathy and chronic glomerulonephritis[J].Clinical Oral Investigations,2013,(02):483-489.
  • 6Qiu H,Fan W,Fu P. General acteoside of rehmanniae leaves in the treatment of primary chronic glomerulonephritis:A randomized controlled trial[J].African Journal of Traditional Complementary and Alternative Medicines,2013,(04):109-115.
  • 7中华人民共和国卫生部.中药新药临床研究指导原则[S]北京:中国医药科技出版社,2002153.
  • 8Olga Litovkina,Elena Nekipelova,Volodymyr Dvornyk,et al.Genes involved in the regulation of vascular homeostasis determine renal survival rate in patients with chronic glomerulonephritis[J].Gene,2014,546(1):112-116.
  • 9Tsuruoka Shuichi,Kai Hirayasu,Usui Joichi,et al.Effects of irbesartan on inflammatory cytokine concentrations in patients with chronic glomerulonephritis[J].Internal Medicine(Online),2013,52(3):303-308.
  • 10Tang J,Liu N,Zhuang S.Role of epidermal growth factor receptor in acute and chronic kidney injury[J].Kidney Int,2013,83(5):804-810.

共引文献135

同被引文献54

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部